Analysis of EPCAM Protein Expression in Diagnostics of Lynch Syndrome
- 10 January 2011
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (2) , 223-227
Abstract
Purpose: Lynch syndrome is an inherited tumor predisposition syndrome caused by germline mutations of DNA mismatch repair (MMR) genes, mainly MLH1 and MSH2. Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel mutational mechanism causing Lynch syndrome by epigenetic inactivation of the respective MSH2 allele. Immunohistochemical analysis of MMR protein expression is a hallmark of Lynch syndrome diagnostics, but it cannot distinguish between EPCAM deletion carriers and MSH2 mutation carriers. We hypothesized that EPCAM protein expression might be altered in tumors from patients with a germline EPCAM deletion. Patients and Methods: Immunohistochemistry was used to assess EPCAM expression in Lynch syndrome–associated MSH2-negative tumors (n = 26). Multiplex ligation-dependent probe amplification (MLPA) analysis was performed to detect germline deletions of the EPCAM and MSH2 gene loci. Results: In four MSH2-negative tumors, a concomitant lack of EPCAM expression was detected. MLPA analysis revealed heterozygous EPCAM deletions in all patients with EPCAM-negative tumors. In contrast, EPCAM expression was positive in all cancers from patients with germline alterations affecting MSH2 but not EPCAM. Two EPCAM deletions were detected in patients with an EPCAM-positive tumor. Conclusion: These results indicate that loss of EPCAM protein expression is frequent in tumors from patients with EPCAM germline deletions. EPCAM immunohistochemistry therefore represents a promising novel tool for the identification of Lynch syndrome patients with EPCAM germline deletions.Keywords
This publication has 18 references indexed in Scilit:
- Hereditary and Familial Colon CancerGastroenterology, 2010
- Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndromeGenes, Chromosomes and Cancer, 2009
- Deletions removing the last exon ofTACSTD1constitute a distinct class of mutations predisposing to Lynch syndromeHuman Mutation, 2009
- Genotype-Phenotype Comparison of German MLH1 and MSH2 Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC ConsortiumJournal of Clinical Oncology, 2006
- Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumorsMolecular Carcinogenesis, 2005
- Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancerInternational Journal of Cancer, 2005
- T25 Repeat in the 3′ Untranslated Region of the CASP2 Gene: A Sensitive and Specific Marker for Microsatellite Instability in Colorectal CancerCancer Research, 2005
- A large MSH2 Alu insertion mutation causes HNPCC in a German kindredHuman Genetics, 2004
- The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferationOncogene, 2004
- The Epithelial Cell Adhesion Molecule (Ep-CAM) as a Morphoregulatory Molecule Is a Tool in Surgical PathologyThe American Journal of Pathology, 2003